Open AccessT cell immunoglobulin and mucin-domain containing-3 in non-small cell lung cancer
Author(s) -
Keyi Jia,
Yayi He,
Rafał Dziadziuszko,
Sha Zhao,
Xiaoshen Zhang,
Juan Deng,
Hao Wang,
Fred R. Hirsch,
Caicun Zhou,
Hui Yu,
Liping Zhang
Publication year - 2019
Publication title -
translational lung cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 41
eISSN - 2226-4477
pISSN - 2218-6751
DOI - 10.21037/tlcr.2019.11.17
Subject(s) - medicine , tumor infiltrating lymphocytes , lung cancer , immunohistochemistry , immunotherapy , mucin , antibody , oncology , cancer , cancer research , immunology , pathology
Immunotherapy has shown promising effect for non-small cell lung cancer (NSCLC) patients. Yet the biomarkers for predicting immunotherapy efficiency are still lacking.